Skip to content
Find a Provider
Allison Taro, PharmD, AAHIVP

Allison Taro, PharmD, AAHIVP

she/her/hers

No ratings currently available, see text in Ratings section below for explanation.

Contact

Call Center (585) 276-3000

About Me

Allison M. Taro (Hitchcock), PharmD, AAHIVP receiver her Doctor of Pharmacy degree from St. John Fisher College, Wegmans School of Pharmacy. She completed a PGY1 Pharmacy Residency and a PGY2 Infectious Diseases Pharmacy Residency at SUNY Upstate Medical University in Syracuse, NY. She began her car...
Allison M. Taro (Hitchcock), PharmD, AAHIVP receiver her Doctor of Pharmacy degree from St. John Fisher College, Wegmans School of Pharmacy. She completed a PGY1 Pharmacy Residency and a PGY2 Infectious Diseases Pharmacy Residency at SUNY Upstate Medical University in Syracuse, NY. She began her career as an Infectious Diseases Clinical Pharmacy Specialist at UPMC Central Pa. in Harrisburg, PA. She subsequently returned to the Rochester, NY where she currently practices as a Clinical Infectious Diseases Pharmacy Specialist at the University of Rochester Medical Center.

Dr. Taro serves as a preceptor for APPE students and PGY-1 and PGY-2 pharmacy residents. Her professional interests include HIV pharmacotherapy and resistance, antimicrobial allergy assessment, and stewardship-focused research. She is also an active member in the Society of Infectious Diseases Pharmacists (SIDP).

Credentials

Residency & Fellowship

PGY2 Infectious Diseases Pharmacy Residency, SUNY Upstate Medical University, Syracuse, NY 2022 - 2023

PGY1 Acute Care Pharmacy Residency, SUNY Upstate Medical University, Syracuse, NY 2021 - 2022

Education

Doctor of Pharmacy | St. John Fisher College/Wegmans School of Pharmacy. 2021

Publications

Journal Articles

Impact of a Pharmacist-Conducted Preoperative Beta-Lactam Allergy Assessment on Perioperative Cefazolin Prescribing.

Hitchcock AM, Kufel WD, Seabury RW, Steele JM

Journal of pharmacy practice.. 2024 October 37 (5):1073-1081. Epub 11/06/2023.

Lenacapavir: A novel injectable HIV-1 capsid inhibitor.

Hitchcock AM, Kufel WD, Dwyer KAM, Sidman EF

International journal of antimicrobial agents.. 2024 January 63 (1):107009. Epub 10/14/2023.

Does a Positive Methicillin-Resistant (MRSA) Nasal Screen Predict the Risk for MRSA Skin and Soft Tissue Infection?

Hitchcock AM, Seabury RW, Kufel WD, Farooqi S, Steele JM, Darko W, Miller CD, Feldman EA

The Annals of pharmacotherapy.. 2023 June 57 (6):669-676. Epub 10/02/2022.

Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance.

Kufel WD, Hitchcock AM, Delbalso AN, Paolino KM

The Journal of antimicrobial chemotherapy.. 2023 April 378 (4):1127-1128. Epub 1900 01 01.

Ratings & Comments

At University of Rochester Medicine, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URochester Medicine partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.